Company Legal Name
Latest Valuation
Founded Year
Headquarter
OpenEvidence Inc. develops AI-powered clinical decision support software that serves as an intelligent copilot for healthcare professionals at the point of care. Founded in 2021 and headquartered in Cambridge, Massachusetts, the company leverages artificial intelligence to assist doctors in making critical medical decisions by providing real-time, evidence-based recommendations. The platform addresses the growing need for enhanced clinical decision-making tools in an increasingly complex healthcare environment. With a current valuation of $3.5 billion, OpenEvidence has established itself as a significant player in the healthcare AI sector. The company continues to focus on expanding its clinical applications and improving diagnostic accuracy for medical professionals.
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.
How can I buy OpenEvidence pre-IPO shares through Jarsy?
You can create an account, complete KYC verification, and start investing from just $10. Shares are fractionalized, so you can access pre-IPO opportunities without high entry barriers.
What is the current stock price and valuation of OpenEvidence ?
The latest valuation of OpenEvidence is 3.5 Billion , The live stock price chart shows historical price movements and company valuation trends. Investors can track performance before the IPO.
What is the minimum investment amount required to invest in OpenEvidence ?
The minimum investment is $10, enabling fractionalized access to OpenEvidence pre-IPO shares.
What fees will I pay when investing in OpenEvidence pre-IPO shares?
Fees include platform fees and carried interest on realized profits.
What risks are involved in OpenEvidence pre-IPO stock investments?
Risks include liquidity lock-ups, valuation uncertainty, industry-specific risks, regulatory changes, and potential custody or tokenization issues.
How does Jarsy ensure transparency of reserves and assets?
Each Jarsy issued Token is backed 1:1 by the economic rights of a corresponding share held by Jarsy’s Delaware LLC ( an LLC created for custody purposes). When a liquidation event happens, Jarsy would liquidate the shares and return the equivalent dollar value to token holders based on their economic interest. This structure ensures full transparency and direct backing of every token. All the supply and transactions information of the token can be verified independently through blockchain.
Can I sell my OpenEvidence pre-IPO shares backed token before the IPO?
You may redeem your tokens through the Jarsy platform; however, settlement is not guaranteed and is subject to available liquidity and market demand.